Cargando…

Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases

Background: Although liver biopsy remains the gold standard for the diagnosis and the monitoring of liver disease, non-invasive biomarkers have been recently suggested to predict liver disease severity, progression, and response to therapy. We investigated multiple tissue and circulating markers of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bocci, Guido, Orlandi, Paola, Manca, Maria Laura, Rossi, Chiara, Salvati, Antonio, Brunetto, Maurizia Rossana, Solini, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604565/ https://www.ncbi.nlm.nih.gov/pubmed/36294318 http://dx.doi.org/10.3390/jcm11205985

Ejemplares similares

Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach
por: Orlandi, Paola, et al.
Publicado: (2021)

The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage
por: Rossi, Chiara, et al.
Publicado: (2022)

Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis
por: De Rosa, Laura, et al.
Publicado: (2022)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study
por: Germanese, Danila, et al.
Publicado: (2019)

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
por: Rebelos, Eleni, et al.
Publicado: (2021)

Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib
por: Colombatto, Piero, et al.
Publicado: (2021)

Circulating Hepatitis B Surface Antigen Particles Carry Hepatocellular microRNAs
por: Novellino, Luisa, et al.
Publicado: (2012)

Urgent Liver Transplantation Soon After Recovery From COVID‐19 in a Patient With Decompensated Liver Cirrhosis
por: Martini, Silvia, et al.
Publicado: (2020)

Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer
por: Miller, Philip C., et al.
Publicado: (2019)

Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral (18)FDG in Mice
por: Guzzardi, Maria Angela, et al.
Publicado: (2022)

Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice
por: Brunetto, Maurizia R.
Publicado: (2020)

Genetic interaction of P2X(7) receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients
por: Solini, Anna, et al.
Publicado: (2015)

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection
por: Cavallone, Daniela, et al.
Publicado: (2023)

Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research
por: Mancini, Marcello, et al.
Publicado: (2018)

Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended
por: Giussani, Marta, et al.
Publicado: (2021)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies
por: Quirico, Lorena, et al.
Publicado: (2020)

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
por: Colombatto, Piero, et al.
Publicado: (2022)

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
por: Bonino, Ferruccio, et al.
Publicado: (2022)

Biopsy Validated Study of Biomarkers for Liver Fibrosis and Transplant Prediction in Inherited Cholestasis
por: Shiau, Henry, et al.
Publicado: (2020)

Maternal High-Fat Feeding Affects the Liver and Thymus Metabolic Axis in the Offspring and Some Effects Are Attenuated by Maternal Diet Normalization in a Minipig Model
por: La Rosa, Federica, et al.
Publicado: (2021)

Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
por: Zhao, An, et al.
Publicado: (2019)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
por: Larrea, Erika, et al.
Publicado: (2016)

Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions
por: Gattuso, Giuseppe, et al.
Publicado: (2022)

Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
por: Roi, Alexandra, et al.
Publicado: (2023)

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
por: Colombatto, Piero, et al.
Publicado: (2022)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019)

Maturation of the Visceral (Gut-Adipose-Liver) Network in Response to the Weaning Reaction versus Adult Age and Impact of Maternal High-Fat Diet
por: Guzzardi, Maria Angela, et al.
Publicado: (2021)

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
por: Bertok, Tomas, et al.
Publicado: (2020)

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
por: Finkle, Justin D., et al.
Publicado: (2021)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Evaluation of visible diffuse reflectance spectroscopy in liver tissue: validation of tissue saturations using extracorporeal circulation
por: Voulgarelis, Stylianos, et al.
Publicado: (2021)

Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
por: Marrugo-Ramírez, José, et al.
Publicado: (2018)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4s51broqtj921ftl18a5geqejj